Literature DB >> 20651171

Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.

Ritu R Gill1, Shigeaki Umeoka, Hatsuho Mamata, Tamara R Tilleman, Peter Stanwell, Reiko Woodhams, Robert F Padera, David J Sugarbaker, Hiroto Hatabu.   

Abstract

OBJECTIVE: The purpose of this study was to prospectively assess, in the evaluation of patients with suspected malignant pleural mesothelioma (MPM), apparent diffusion coefficient (ADC) values derived from diffusion-weighted images obtained with a free-breathing single-shot spin-echo echo-planar imaging sequence and to correlate the ADC values with the three histologic subtypes of MPM. SUBJECTS AND METHODS: Sixty-two patients with a known pleural abnormality and clinical findings suggestive of MPM underwent diffusion-weighted 3-T MRI and ADC calculation. The pathologic diagnosis was confirmed by surgical procedure. ADC values were correlated with the histologic subtypes of MPM. Statistical analysis was performed with analysis of variance and the Student's t test.
RESULTS: Fifty-seven patients had MPM. Forty of the tumors were epithelioid, 11 were biphasic, and six were sarcomatoid. The other five patients had pleural thickening (two patients), metastatic adenocarcinoma (one patient), chronic inflammation (one patient), and malignant lymphoma (one patient). Because of image distortion, the diffusion-weighted images and ADC maps were not satisfactory for assessment in seven cases. The ADC values of MPM were 1.31 +/- 0.15 x 10(-3) mm(2)/s for the epithelioid, 1.01 +/- 0.11 x 10(-3) mm(2)/s for the biphasic, and 0.99 +/- 0.07 x 10(-3) mm(2)/s for the sarcomatoid subtypes of MPM. The ADC of the epithelioid subtype was statistically significantly higher than that of the sarcomatoid subtype (p < 0.05). The ADC in the two cases of benign plaque was 0.85 +/- 0.17 x 10(-3) mm(2)/s.
CONCLUSION: The ADC values of epithelioid mesothelioma are higher than those of sarcomatoid mesothelioma. There is no significant difference between the ACD values of biphasic and those of sarcomatoid MPM.

Entities:  

Mesh:

Year:  2010        PMID: 20651171     DOI: 10.2214/AJR.09.3519

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

Review 1.  Overview of treatment related complications in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

Review 2.  Malignant pleural mesothelioma: predictors and staging.

Authors:  William G Richards
Journal:  Ann Transl Med       Date:  2017-06

Review 3.  Volumetric assessment in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

4.  Role of respiratory-triggered diffusion-weighted MRI in the assessment of pleural disease.

Authors:  Matteo Revelli; Fabio Chiesa; Alberto Del Prato; Alberto Tagliafico; Ilan Rosenberg; Pier Aldo Canessa; Valentina Pinelli; Alessandro Villa
Journal:  Br J Radiol       Date:  2016-06-15       Impact factor: 3.039

5.  The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

Authors:  Akash M Patel; Ian Berger; E Paul Wileyto; Urooj Khalid; Drew A Torigian; Arun C Nachiappan; Eduardo M Barbosa; Warren B Gefter; Maya Galperin-Aizenberg; Narainder K Gupta; Charles B Simone; Andrew R Haas; Evan W Alley; Sunil Singhal; Keith A Cengel; Sharyn I Katz
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 6.  New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.

Authors:  Anne S Tsao; Harvey I Pass; Andreas Rimner; Aaron S Mansfield
Journal:  J Clin Oncol       Date:  2022-01-05       Impact factor: 44.544

7.  Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography?

Authors:  Joanna G Escalon; Kate A Harrington; Andrew J Plodkowski; Junting Zheng; Marinela Capanu; Marjorie G Zauderer; Valerie W Rusch; Michelle S Ginsberg
Journal:  J Comput Assist Tomogr       Date:  2018 Jul/Aug       Impact factor: 1.826

Review 8.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

9.  Imaging characteristics of pleural tumours.

Authors:  Luca De Paoli; Emilio Quaia; Gabriele Poillucci; Antonio Gennari; Maria Assunta Cova
Journal:  Insights Imaging       Date:  2015-10-16

Review 10.  Diffusion magnetic resonance imaging of chest tumors.

Authors:  A A K Abdel Razek
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.